{
  "doc_id": "ipc6-p1002methicillin-resistantstaphylococcusaureus_385ab7bec550",
  "total_chunks": 4,
  "chunks": [
    {
      "chunk_id": "ipc6-p1002methicillin-resistantstaphylococcusaureus_385ab7bec550_chunk_000_6b45971b",
      "doc_id": "ipc6-p1002methicillin-resistantstaphylococcusaureus_385ab7bec550",
      "chunk_index": 0,
      "text": "# Extendicare## PROCEDURE**MANUAL:** Infection Prevention and Control\n**INDEX:** IPC6-P10.02\n**SECTION:** Multi-Drug-Resistant Organisms (MDROs)\n**DESCRIPTION:** Methicillin Resistant Staphylococcus Aureus (MRSA)\n**APPROVED BY:** Chief Medical Officer\n**EFFECTIVE DATE:** February 18, 2025\n**REVIEWED DATE:** February 11, 2025\n**MODIFIED DATE:** May 30, 2025----## POLICY### Multi-Drug-Resistant Organisms (MDROs)## PROCEDURE### Screening\n- The MDRO Screening Tool will be completed within 24 hours of admission or readmission from hospital where stay was greater than 12 hours. - If warranted by the MDRO Screening Tool or per health authority requirements, collect surveillance specimens for MRSA. - Screening includes:\n- Anterior nares\n- Perianal, perineal or groin area (perianal preferred)\n- Open wounds, skin lesions, incisions, ulcers and exit site of indwelling devices, if present\n- Laboratory results will be recorded in the health care record and HealthConnex (if applicable).### Management\n- Decolonization is not effective and not recommended. - For a MRSA infection, implement Contact Precautions and as per health authority guidelines.",
      "char_count": 1150,
      "token_estimate": 287,
      "section_title": null,
      "chunk_type": "content",
      "start_line": null,
      "end_line": null
    },
    {
      "chunk_id": "ipc6-p1002methicillin-resistantstaphylococcusaureus_385ab7bec550_chunk_001_aeecbf0e",
      "doc_id": "ipc6-p1002methicillin-resistantstaphylococcusaureus_385ab7bec550",
      "chunk_index": 1,
      "text": "- Screening includes:\n- Anterior nares\n- Perianal, perineal or groin area (perianal preferred)\n- Open wounds, skin lesions, incisions, ulcers and exit site of indwelling devices, if present\n- Laboratory results will be recorded in the health care record and HealthConnex (if applicable).### Management\n- Decolonization is not effective and not recommended. - For a MRSA infection, implement Contact Precautions and as per health authority guidelines. - For a MRSA colonization, implement Contact Precautions for direct care. - Follow VRE & MRSA Screening Surveillance Algorithm for surveillance testing.### Retirement Specific:\n- If MRSA is identified, it will be noted on the plan of care. Appropriate precautions will remain in place until it is cleared, or the Resident moves out.### Alberta and Manitoba Specific:\n- Admission testing for MRSA is not recommended. - Maintain routine practices, implement additional precautions if required based on a risk assessment.## EDUCATION\nHelplng people\nIva better----> This document is uncontrolled when printed. > Extendicare (Canada) Inc.",
      "char_count": 1084,
      "token_estimate": 271,
      "section_title": null,
      "chunk_type": "content",
      "start_line": null,
      "end_line": null
    },
    {
      "chunk_id": "ipc6-p1002methicillin-resistantstaphylococcusaureus_385ab7bec550_chunk_002_000bab5a",
      "doc_id": "ipc6-p1002methicillin-resistantstaphylococcusaureus_385ab7bec550",
      "chunk_index": 2,
      "text": "- Maintain routine practices, implement additional precautions if required based on a risk assessment.## EDUCATION\nHelplng people\nIva better----> This document is uncontrolled when printed. > Extendicare (Canada) Inc. will provide, on request, information in an accessible format or with communication supports to people with disabilities, in a manner that takes into account their disability. Confidential and Proprietary Information of Extendicare (Canada) Inc. © 2025\n> Page 1 of 2# PROCEDURE## SECTION: Multi-Drug-Resistant Organisms (MDROs)### DESCRIPTION: Methicillin Resistant Staphylococcus Aureus (MRSA)#### INDEX: IPC6-P10.021. **IPC6-P10-E1** - MDRO Guide",
      "char_count": 666,
      "token_estimate": 166,
      "section_title": null,
      "chunk_type": "content",
      "start_line": null,
      "end_line": null
    },
    {
      "chunk_id": "ipc6-p1002methicillin-resistantstaphylococcusaureus_385ab7bec550_chunk_003_1af1d554",
      "doc_id": "ipc6-p1002methicillin-resistantstaphylococcusaureus_385ab7bec550",
      "chunk_index": 3,
      "text": "2. **IPC6-P10-E3** - Methicillin Resistant Staphylococcus aureus (MRSA) Fact Sheet### TOOLS1. **IPC6-P10-T1** – MDRO Screening Tool\n\n2. **IPC6-P10-T5** - Testing Program for Multi-Drug-Resistant-Organism (MDRO) Algorithm----Helping people live betterThis document is uncontrolled when printed. Extendicare (Canada) Inc. will provide, on request, information in an accessible format or with communication supports to people with disabilities, in a manner that takes into account their disability. Confidential and Proprietary Information of Extendicare (Canada) Inc. © 2025----Page 2 of 2",
      "char_count": 587,
      "token_estimate": 146,
      "section_title": "**IPC6-P10-E3** - Methicillin Resistant Staphylococcus aureus (MRSA) Fact Sheet### TOOLS1. **IPC6-P10-T1** – MDRO Screening Tool",
      "chunk_type": "content",
      "start_line": null,
      "end_line": null
    }
  ]
}